Kezar Life Sciences Inc.

NASDAQ: KZR · Real-Time Price · USD
3.97
-0.01 (-0.25%)
At close: Aug 15, 2025, 3:59 PM
4.07
2.52%
After-hours: Aug 15, 2025, 07:48 PM EDT

Kezar Life Sciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-70.79M -78.63M -83.74M -95.78M -98.57M -101.33M -101.87M -87.79M -82.53M -74.41M -68.24M -64.27M -60.88M -57.66M -54.63M -51.36M -48.19M -44.72M
Depreciation & Amortization
-3.7M -3.1M -3.09M -3.07M 1.08M 1.07M 1.07M 503K 683K 865K 1.02M 1.69M 1.61M 1.55M 1.51M 1.49M 1.56M 1.55M
Stock-Based Compensation
11.69M 12.36M 13.01M 12.92M 16.37M 17.31M 18.14M 18.73M 15.89M 15.16M 14.01M 12.04M 10.13M 8.77M 7.6M 7.02M 6.42M 5.7M
Other Working Capital
3.67M 4.72M 3.81M 1.99M 2.74M 801K -1.64M -4.34M -10.46M -10.96M -8.45M -5.71M -1.24M -1.09M 9K -1.14M -2.25M -1.12M
Other Non-Cash Items
-1.54M -147K -1.07M 4.03M 3.09M 2.92M 2.72M -2.83M -3.46M -3.47M -1.76M -58K 922K 1.4M 1.86M 1.86M 1.54M 927K
Deferred Income Tax
n/a n/a n/a -2.82M -4.58M -6.4M -6.4M -3.58M -1.82M n/a 339K 339K 339K 339K n/a n/a n/a n/a
Change in Working Capital
37K 982K 668K 8.35M 3.53M 2.79M 4.71M -3.58M -3.46M -4.79M -4.46M -4.03M -4K -1.8M 1.23M 321K -1.29M -460K
Operating Cash Flow
-64.3M -68.54M -74.21M -76.37M -79.08M -83.65M -81.64M -78.55M -74.7M -66.39M -58.85M -54.04M -47.64M -47.39M -42.44M -40.66M -39.96M -37.01M
Capital Expenditures
-37K -37K -29K -19K -137K -1.51M -1.81M -2.15M -2.62M -1.43M -1.58M -1.5M -924K -766K -316K -134K -108K -101K
Cash Acquisitions
n/a n/a n/a n/a 5K -9.58K -26.27K -17.95K 1.16K 15.73K 32.42K 24.11K n/a n/a n/a n/a n/a n/a
Purchase of Investments
-67.55M -74M -91.34M -121.97M -137.29M -143.68M -180.4M -224.1M -285.36M -311.74M -332.2M -351.86M -260.55M -204.71M -156.38M -86.21M -119.86M -179.4M
Sales Maturities Of Investments
140.53M 147.79M 171.79M 206.55M 216.5M 225.25M 258.25M 265.75M 284.2M 297.7M 242.39M 188.14M 159.44M 118.19M 128.25M 157.71M 155.64M 161.64M
Other Investing Acitivies
n/a n/a n/a n/a n/a 14.58K 31.27K 22.95K -1.16K 1.68M -57.42M -139.64M -101.11M -86.52M -28.13M 71.5M 35.78M -17.75M
Investing Cash Flow
72.94M 73.76M 80.43M 84.56M 79.08M 80.06M 76.05M 39.51M -3.77M -15.47M -91.39M -165.22M -102.03M -87.29M -28.44M 71.36M 35.67M -17.86M
Debt Repayment
-1.3M -1.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-1.17M 103K 103K 638K 638K 638K 638K 1.32M 1.32M 1.32M 1.32M 9.53M 9.53M 9.53M 9.53M n/a n/a n/a
Financial Cash Flow
-2.53M -1.2M 103K 115K 158K 484K 638K 1.08M 1.23M 79.17M 127.86M 226.71M 228.74M 150.7M 112.58M 13.55M 13.3M 57.01M
Net Cash Flow
6.09M 3.97M 6.26M 8.36M 167K -3.1M -4.96M -37.95M -77.28M -2.78M -22.43M 7.36M 79M 16M 41.65M 44.26M 9.09M 2.34M
Free Cash Flow
-64.34M -68.58M -74.24M -76.39M -79.22M -85.16M -83.45M -80.7M -77.32M -67.82M -60.42M -55.55M -48.56M -48.16M -42.75M -40.8M -40.07M -37.11M